Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe-Reference-Cited by-同舟云学术

Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe

Published:2024-05-01 Issue:3 Volume:28 Page:275-284
ISSN:1226-4512
Container-title:The Korean Journal of Physiology & Pharmacology
language:en
Short-container-title:Korean J Physiol Pharmacol

Author:

Metwally Mohamed Ali¹,El-Zawahry El-Yamani Ibrahim²,Ali Maher Amer³,Ibrahim Diaa Farrag¹,Sabry Shereen Ahmed⁴,Sarhan Omnia Mohamed⁵

Affiliation:

1. Department of Zoology, Faculty of Science, Al-Azhar University, Cairo 11651, Egypt

2. Department of Zoology, Faculty of Science, Zagazig University, Zagazig 44519, Egypt

3. Department of Zoology, Faculty of Science, Mansoura University, Mansoura 35516, Egypt

4. Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt

5. Department of Pharmaceutics, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt

Publisher

The Korean Physiological Society and The Korean Society of Pharmacology

Link

https://pdf.medrang.co.kr/KJPP2/2024/028/KJPP028-03-09.pdf

Reference65 articles.

1. Hyperlipidemia as a Risk Factor for Cardiovascular Disease

2. Skolnik N, Jaffa FM, Kalyani RR, Johnson E, Shubrook JH. Reducing CV risk in diabetes: an ADA update. J Fam Pract. 2017;66:300-308.

3. Cholesterol ester transfer protein and apolipoprotein E gene polymorphisms in hyperlipidemic Asian Indians in North India

4. Alissa EM, Ferns GA. Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr. 2017;57:1950-1962.

5. Keshetty V, Pabba S, Gudipati R, Kandukuri JM, Allenki V. Antihyperlipidemic activity of methanolic extract of Garlic (Alliumsativum L.) in Triton X-100 induced hyperlipidemic rats. J Pharm Res. 2009;2:777-780.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum to: Development and assessment of nano drug delivery systems for combined delivery of rosuvastatin and ezetimibe;The Korean Journal of Physiology & Pharmacology;2024-07-01